GD2-specific chimeric antigen receptor-modified T cells for the treatment of refractory and/or recurrent neuroblastoma in pediatric patients - Concepedia

Concepedia

Publication | Open Access

GD2-specific chimeric antigen receptor-modified T cells for the treatment of refractory and/or recurrent neuroblastoma in pediatric patients

DOI Full Paper Access

74

Citations

30

References

2021

Year

Lihua Yu, Lulu Huang, Danna Lin, Xiaorong Lai, Li Wu, Xu Liao, Jiale Liu, Yinghua Zeng, Lichan Liang, Guanmei Zhang,

Journal of Cancer Research and Clinical Oncology

Abstract

The 4SCAR-GD2 T-cell therapy demonstrated antitumor effect and manageable toxicities, indicating its potential to benefit children with refractory and/or recurrent NB.

References

	Year	Citations

Page 1